Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Richard DiMarchi PhD

Richard DiMarchi PhD

Distinguished Professor, Linda & Jack Gill Chair in Biomolecular Science, Department of Chemistry, Indiana University Bloomington, Bloomington, Indiana

Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University. He served as Group Vice President at Eli Lilly and later Vice President at Novo Nordisk. He is recognized for his contributions to the discovery and development of rDNA-derived Humalog®, rGlucagon®, and Forteo®. His academic research has broadened the understanding of glucagon physiology and the discovery of single molecule multimode agonists for the treatment of diabetes and obesity. He is a member of the National Academy of Medicine and the National Inventors Hall of Fame.


Dr. Marchi has no conflicts to declare that pertain to this subject.